Cyclooxygenase Inhibitors
"Cyclooxygenase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.
| Descriptor ID |
D016861
|
| MeSH Number(s) |
D27.505.519.389.310 D27.505.696.663.850.014.040.500.500 D27.505.954.158.030.500 D27.505.954.329.030.500
|
| Concept/Terms |
Cyclooxygenase Inhibitors- Cyclooxygenase Inhibitors
- Inhibitors, Cyclo-Oxygenase
- Inhibitors, Cyclo Oxygenase
- Inhibitors, Cyclooxygenase
- Prostaglandin Synthesis Antagonists
- Antagonists, Prostaglandin Synthesis
- Inhibitors, Prostaglandin-Endoperoxide Synthase
- Inhibitors, Prostaglandin Endoperoxide Synthase
- Prostaglandin Endoperoxide Synthase Inhibitors
- Prostaglandin Synthase Inhibitors
- Cyclo-Oxygenase Inhibitors
- Cyclo Oxygenase Inhibitors
- Inhibitors, Prostaglandin Synthase
|
Below are MeSH descriptors whose meaning is more general than "Cyclooxygenase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cyclooxygenase Inhibitors".
This graph shows the total number of publications written about "Cyclooxygenase Inhibitors" by people in this website by year, and whether "Cyclooxygenase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 2 | 3 | 5 |
| 2003 | 0 | 1 | 1 |
| 2004 | 3 | 2 | 5 |
| 2005 | 2 | 8 | 10 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 3 | 3 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclooxygenase Inhibitors" by people in Profiles.
-
Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016. Am J Cardiol. 2021 08 01; 152:168.
-
Maternal low body mass index is a risk factor for fetal ductal constriction following indomethacin use among women undergoing fetal repair of spina bifida. Prenat Diagn. 2020 05; 40(6):669-673.
-
Automated identification of an aspirin-exacerbated respiratory disease cohort. J Allergy Clin Immunol. 2017 Mar; 139(3):819-825.e6.
-
Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants. J Neonatal Perinatal Med. 2014 Jan 01; 7(3):229-35.
-
Cyclooxygenase reaction mechanism of PGHS--evidence for a reversible transition between a pentadienyl radical and a new tyrosyl radical by nitric oxide trapping. J Inorg Biochem. 2011 Mar; 105(3):356-65.
-
Structural comparisons of arachidonic acid-induced radicals formed by prostaglandin H synthase-1 and -2. J Inorg Biochem. 2011 Mar; 105(3):366-74.
-
Prostaglandin E2 is activated by airway injury and regulates fibroblast cytoskeletal dynamics. Laryngoscope. 2009 Jul; 119(7):1365-73.
-
Augmentation of U46619 induced human platelet aggregation by aspirin. Platelets. 2009 Mar; 20(2):111-9.
-
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J. 2009 Apr; 157(4):606-12.
-
Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib. Cancer Prev Res (Phila). 2009 Feb; 2(2):168-74.